• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微针阵列介导的细菌皮内递药。

Intradermal Delivery of Bacteria by Using Microneedle Arrays.

机构信息

Department of Microbial Pathogenesis, University of Maryland-Baltimore, Baltimore, Maryland, USA.

Laboratory of Systems Biology, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.

出版信息

Infect Immun. 2018 Aug 22;86(9). doi: 10.1128/IAI.00406-18. Print 2018 Sep.

DOI:10.1128/IAI.00406-18
PMID:29986891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6105887/
Abstract

Infectious diseases propagated by arthropod vectors, such as tularemia, are commonly initiated via dermal infection of the skin. However, due to the technical difficulties in achieving accurate and reproducible dermal deposition, intradermal models are less commonly used. To overcome these limitations, we used microneedle arrays (MNAs), which are micron-scale polymeric structures, to temporarily disrupt the barrier function of the skin and deliver a bacterial inoculum directly to the dermis of an animal. MNAs increase reliability by eliminating leakage of the inoculum or blood from the injection site, thereby providing a biologically relevant model for arthropod-initiated disease. Here, we validate the use of MNAs as a means to induce intradermal infection using a murine model of tularemia initiated by We demonstrate targeted delivery of the MNA bolus to the dermal layer of the skin, which subsequently led to innate immune cell infiltration. Additionally, -coated MNAs were used to achieve lethality in a dose-dependent manner in C57BL/6 mice. The immune profile of infected mice mirrored that of established infection models, consisting of markedly increased serum levels of interleukin-6 and keratinocyte chemoattractant, splenic T-cell depletion, and an increase in splenic granulocytes, together confirming that MNAs can be used to reproducibly induce tularemia-like pathogenesis in mice. When MNAs were used to immunize mice using an attenuated mutant ( Δ), all immunized mice survived a lethal subcutaneous challenge. Thus, MNAs can be used to effectively deliver viable bacteria and provide a novel avenue to study intradermally induced microbial diseases in animal models.

摘要

通过节肢动物媒介传播的传染病,如兔热病,通常通过皮肤的皮肤感染开始。然而,由于实现精确和可重复的皮肤沉积的技术困难,皮内模型的使用较少。为了克服这些限制,我们使用微针阵列(MNAs),这是一种微米级的聚合物结构,暂时破坏皮肤的屏障功能,并将细菌接种物直接递送至动物的真皮。MNAs 通过消除接种物或血液从注射部位泄漏来提高可靠性,从而为节肢动物引发的疾病提供了一种生物学上相关的模型。在这里,我们使用兔热病的小鼠模型验证了 MNAs 作为诱导皮内感染的手段的使用。我们证明了 MNA 团块靶向递送至皮肤的真皮层,随后导致固有免疫细胞浸润。此外,用 涂层 MNAs 以剂量依赖的方式在 C57BL/6 小鼠中实现致死性。感染小鼠的免疫谱与已建立的 感染模型相似,包括白细胞介素-6 和角质形成细胞趋化因子的血清水平显着增加,脾 T 细胞耗竭以及脾粒细胞增加,共同证实 MNAs 可用于在小鼠中重现性地诱导兔热病样发病机制。当使用减毒 突变体(Δ)通过 MNAs 对小鼠进行免疫时,所有免疫的小鼠都能在致命的皮下挑战中存活下来。因此,MNAs 可用于有效递送电活细菌,并为在动物模型中研究皮内诱导的微生物疾病提供了新途径。

相似文献

1
Intradermal Delivery of Bacteria by Using Microneedle Arrays.微针阵列介导的细菌皮内递药。
Infect Immun. 2018 Aug 22;86(9). doi: 10.1128/IAI.00406-18. Print 2018 Sep.
2
Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia.用特定减毒的新凶手弗朗西斯菌菌株进行鼻内接种可诱导γ干扰素依赖性抗体介导的兔热病保护作用。
Infect Immun. 2006 Apr;74(4):2063-71. doi: 10.1128/IAI.74.4.2063-2071.2006.
3
BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses.BALB/c 小鼠,但不是用弗朗西斯氏菌属土拉弗朗西斯菌亚种的 ΔclpB 突变体免疫的 C57BL/6 小鼠,可免受野生型细菌的呼吸道挑战:保护与接种后和接种后免疫反应有关。
Vaccine. 2012 May 21;30(24):3634-45. doi: 10.1016/j.vaccine.2012.03.036. Epub 2012 Apr 3.
4
Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.用土拉弗朗西斯菌活疫苗株进行气溶胶免疫(而非皮内免疫),可通过αβ T细胞和γ干扰素依赖机制,保护小鼠免受该病原体高毒力A型菌株随后的气溶胶攻击。
Vaccine. 2005 Mar 31;23(19):2477-85. doi: 10.1016/j.vaccine.2004.10.034.
5
Therapeutic intradermal delivery of tumor necrosis factor-alpha antibodies using tip-loaded dissolvable microneedle arrays.使用尖端加载的可溶解微针阵列进行肿瘤坏死因子-α抗体的治疗性皮内递送。
Acta Biomater. 2015 Sep;24:96-105. doi: 10.1016/j.actbio.2015.05.036. Epub 2015 Jun 18.
6
CD4+ T cells are required during priming but not the effector phase of antibody-mediated IFN-gamma-dependent protective immunity against pulmonary Francisella novicida infection.在针对肺部新凶手弗朗西斯菌感染的抗体介导的干扰素-γ依赖性保护性免疫的启动阶段而非效应阶段,CD4 + T细胞是必需的。
Immunol Cell Biol. 2008 Aug-Sep;86(6):515-22. doi: 10.1038/icb.2008.31. Epub 2008 Apr 22.
7
Mice sublethally infected with Francisella novicida U112 develop only marginal protective immunity against systemic or aerosol challenge with virulent type A or B strains of F. tularensis.用新凶手弗朗西斯菌U112进行亚致死感染的小鼠,对强毒A型或B型土拉弗朗西斯菌的全身或气溶胶攻击仅产生微弱的保护性免疫。
Microb Pathog. 2004 Aug;37(2):107-10. doi: 10.1016/j.micpath.2004.04.005.
8
Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.用土拉弗朗西斯菌活疫苗株(LVS)对小鼠进行口服免疫,可保护小鼠免受强毒A型土拉弗朗西斯菌的呼吸道攻击。
Vaccine. 2007 May 10;25(19):3781-91. doi: 10.1016/j.vaccine.2007.02.014. Epub 2007 Feb 26.
9
Generation of protection against Francisella novicida in mice depends on the pathogenicity protein PdpA, but not PdpC or PdpD.在小鼠体内产生对弗朗西斯氏菌 novicida 的保护作用依赖于致病性蛋白 PdpA,但不依赖于 PdpC 或 PdpD。
Microbes Infect. 2013 Nov;15(12):816-27. doi: 10.1016/j.micinf.2013.07.005. Epub 2013 Jul 20.
10
Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge.减毒的新凶手弗朗西斯菌转座子突变体可保护小鼠免受野生型菌株的攻击。
Infect Immun. 2006 Sep;74(9):5095-105. doi: 10.1128/IAI.00598-06.

引用本文的文献

1
Microneedle array delivery of recapitulates bubonic plague.微针阵列递送模拟腺鼠疫。
iScience. 2023 Nov 30;27(1):108600. doi: 10.1016/j.isci.2023.108600. eCollection 2024 Jan 19.
2
Tuning innate immune function using microneedles containing multiple classes of toll-like receptor agonists.利用包含多种类别的 Toll 样受体激动剂的微针来调节固有免疫功能。
Nanoscale. 2023 May 18;15(19):8662-8674. doi: 10.1039/d3nr00333g.
3
Harnessing Biomaterials to Study and Direct Antigen-Specific Immunotherapy.利用生物材料研究和指导抗原特异性免疫疗法。
ACS Appl Bio Mater. 2023 Jun 19;6(6):2017-2028. doi: 10.1021/acsabm.3c00136. Epub 2023 Apr 17.
4
Microneedle arrays integrated with living organisms for smart biomedical applications.微针阵列与生物体集成用于智能生物医学应用。
Theranostics. 2021 Oct 25;11(20):10012-10029. doi: 10.7150/thno.66478. eCollection 2021.
5
Optimisation of Design and Manufacturing Parameters of 3D Printed Solid Microneedles for Improved Strength, Sharpness, and Drug Delivery.用于提高强度、尖锐度和药物递送的3D打印实心微针的设计与制造参数优化
Micromachines (Basel). 2021 Jan 22;12(2):117. doi: 10.3390/mi12020117.
6
Progress in microneedle array patch (MAP) for vaccine delivery.微针贴片(MAP)在疫苗传递方面的进展。
Hum Vaccin Immunother. 2021 Jan 2;17(1):316-327. doi: 10.1080/21645515.2020.1767997. Epub 2020 Jul 15.
7
Microneedle Coating Methods: A Review with a Perspective.微针涂层方法:综述与展望。
J Pharmacol Exp Ther. 2019 Sep;370(3):555-569. doi: 10.1124/jpet.119.258707. Epub 2019 Jun 7.

本文引用的文献

1
Improving Vaccine and Immunotherapy Design Using Biomaterials.利用生物材料改进疫苗和免疫疗法设计。
Trends Immunol. 2018 Feb;39(2):135-150. doi: 10.1016/j.it.2017.10.002. Epub 2017 Dec 14.
2
Host-based lipid inflammation drives pathogenesis in infection.基于宿主的脂质炎症驱动 感染的发病机制。
Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):12596-12601. doi: 10.1073/pnas.1712887114. Epub 2017 Nov 6.
3
The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial.微针贴片(TIV-MNP 2015)接种灭活流感疫苗的安全性、免疫原性和可接受性:一项随机、部分盲法、安慰剂对照、1 期临床试验。
Lancet. 2017 Aug 12;390(10095):649-658. doi: 10.1016/S0140-6736(17)30575-5. Epub 2017 Jun 27.
4
Increased Resistance to Intradermal Francisella tularensis LVS Infection by Inactivation of the Sts Phosphatases.通过Sts磷酸酶失活增强对皮内土拉弗朗西斯菌LVS感染的抵抗力。
Infect Immun. 2017 Aug 18;85(9). doi: 10.1128/IAI.00406-17. Print 2017 Sep.
5
Expansion of Melanoma-Specific T Cells Using Microneedle Arrays Coated with Immune-Polyelectrolyte Multilayers.使用涂覆有免疫聚电解质多层膜的微针阵列扩增黑色素瘤特异性T细胞。
ACS Biomater Sci Eng. 2017 Feb 13;3(2):195-205. doi: 10.1021/acsbiomaterials.6b00414. Epub 2016 Sep 1.
6
Francisella tularensis prevalence and load in Dermacentor reticulatus ticks in an endemic area in Central Europe.中欧某流行地区网纹革蜱中兔热病弗朗西斯菌的流行率和载量
Med Vet Entomol. 2017 Jun;31(2):234-239. doi: 10.1111/mve.12229. Epub 2017 Mar 3.
7
Neutrophil swarming: an essential process of the neutrophil tissue response.中性粒细胞聚集:中性粒细胞组织反应的一个必要过程。
Immunol Rev. 2016 Sep;273(1):76-93. doi: 10.1111/imr.12458.
8
An Immature Myeloid/Myeloid-Suppressor Cell Response Associated with Necrotizing Inflammation Mediates Lethal Pulmonary Tularemia.与坏死性炎症相关的未成熟髓样/髓样抑制细胞反应介导致死性肺土拉菌病。
PLoS Pathog. 2016 Mar 25;12(3):e1005517. doi: 10.1371/journal.ppat.1005517. eCollection 2016 Mar.
9
"FoxP3 Hunting" during infection with Francisella tularensis.土拉弗朗西斯菌感染期间的“FoxP3搜寻”
Int J Immunopathol Pharmacol. 2014 Oct-Dec;27(4):585-95. doi: 10.1177/039463201402700414.
10
B cell subsets are activated and produce cytokines during early phases of Francisella tularensis LVS infection.在土拉弗朗西斯菌LVS感染的早期阶段,B细胞亚群被激活并产生细胞因子。
Microb Pathog. 2014 Oct;75:49-58. doi: 10.1016/j.micpath.2014.08.009. Epub 2014 Sep 6.